
US open: Omicron vaccine concerns send stocks lower
US futures are trading lower after Modern's warning that current COVID vaccines are unlikely to protect against Omicron.
Share this:
US futures
Dow futures -0.93% at 34794
S&P futures -0.77% at 4617
Nasdaq futures -0.46% at 16318
In Europe
FTSE -0.7% at 7070
Dax -0.71% at 15181
Euro Stoxx -0.7% at 4080
Learn more about trading indices
Vaccine efficacy looks doubtful
US stocks once again set to start sharply lower amid revived Omicron fears, although the futures have picked up off their lows.
The mood in the market soured after Moderna’s chief executive Stephane Bancel warned that current COVID vaccines are unlikely to be as effective against the new Omicron variant. He added that large scale manufacturing of variant specific vaccines.
The revelation has prompted investors to take risk off the table and is in sharp contrast to the rally in risk assets yesterday. There is still a lot of unknowns regarding Omicron so we can expect the market to react strongly as new pieces of information come to light. Volatility is going to be high over the coming two weeks whilst the market pieces together the threat that Omicron poses to the global economic recovery.
Modern’s chief executive wasn’t the only one spooking the markets, Fed Chair Powell also unnerved investors with comments yesterday that Omicron poses a challenge to both of the Fed’s targets – price stability and full employment suggesting that the Fed could well hold off on tightening monetary policy further.
Powell and Treasury Secretary Janet Yellen are due to testify before the Senate Banking Committee.
Banking stocks could come under pressure as expectations of a rate hike cools, travel and tourism stocks in addition to oil majors are all likely to come under pressure.
Where next for the Dow Jones?
The Dow Jones is resuming its downward trajectory. The index continues to trade below its 50 sma and found support at its 200 sma at 34430. The 200sma is a pretty key support level which hasn’t been breached since July last year. A close below here would be significant, opening the door to greater losses. It would take a move above the 50 sma at 35331 and the previous resistance at 35500to negate the near term down trend.
FX – USD falls on dovish Fed, EUR rises as CPI hits record high
The USD is falling sharply following Fed Powell’s dovish comments in the previous session which caused investors to push back on expectations of an interest rate rise given the uncertainty surrounding the outlook.
EUR/USD is charging higher thanks in part to the weaker US dollar and thanks to surging inflation in the Eurozone. Eurozone inflation jumped to 4.9% in November a record high, well above the 4.5% forecast and up from 4.1% in October. Higher energy prices and supply chain disruptions were the main contributors to rising prices. Energy is on track for its highest annual rise in November at 27.4%.
GBP/USD +0.16% at 1.3336
EUR/USD +0.56% at 1.1356
Oil resumes decline of lockdown, travel restriction fears
Oil prices are falling, paring gains from the previous session amid concerns that current vaccines won’t protect against the Omicron strain of COVID. Comments by Moderna’s chief executive raising doubts over the vaccine’s efficacy, combined with a warning from Fed Chair Powell that Omicron will slow the economic recovery has clouded oil demand outlook.
The obvious concern is more travel restrictions. However, these could be imposed by governments or quite simply people chose to travel less.
Expectations are growing the OPEC+ put on hold plans to increase oil supply give the uncertainty.
Looking ahead the release of API stock pile data could attract some attention, although Omicron headlines are likely to be the biggest driver.
WTI crude trades -2.5% at $67.94
Brent trades -2.7% at $71.09
Learn more about trading oil here.
Looking ahead
14:00 US Homes Sales
15:00 US Consumer Confidence
15:00 Fed Chair Powell Speech
21:30 API Crude Oil Stock
Follow these easy steps to start trading with City Index today:
- Open a City Index account, or log-in if you’re already a customer.
- Search for the market you want to trade in our award-winning platform.
- Choose your position and size, and your stop and limit levels
- Place the trade.
How to trade with FOREX.com
You can trade with FOREX.com by following these four easy steps:
- Open an account, or log in if you’re already a customer
- Search for the instrument you want to trade in our award-winning platform
- Choose your position and size, and your stop and limit levels
- Place the trade
Related tags:
Latest market news
View more newsOpen an account today
Experience award-winning platforms with fast and secure execution.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

Euro Short-term Outlook: EUR/USD Plunges to 19-Month Low—Bears Face Critical Test 11 18 2026
The Euro selloff is now approaching pivotal support, raising the prospect of downside exhaustion as the November decline extends.

Silver Analysis: XAG/USD Continues to Set New Lows for the Year
It continues to be a challenging period for the silver market in the short term, as the precious metal remains under pressure and keeps posting new lows on a consistent basis. Over the last five trading sessions alone, silver has fallen nearly 12%, a move that has highlighted a strong bearish bias not seen in the market for several months.

Japanese Yen Technical Outlook: USD/JPY Rally Stalls Near 160—Breakout Support in Focus 11 18 2026
USD/JPY has set its weekly range just above former resistance, with a range break likely to determine whether November’s rally has further to run.
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.





